OTCMKTS:WILYY Demant A/S (WILYY) Stock Price, News & Analysis → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free WILYY Stock Alerts $22.85 0.00 (0.00%) (As of 05/14/2024 ET) Add Compare Share Share Today's Range$22.85▼$22.8550-Day Range$21.84▼$26.8552-Week Range$21.50▼$27.06Volume10 shsAverage Volume253 shsMarket Capitalization$10.23 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest Get Demant A/S alerts: Email Address Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide About Demant A/S Stock (OTCMKTS:WILYY)Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets and solutions for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.Read More WILYY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart WILYY Stock News HeadlinesMay 11, 2024 | americanbankingnews.comDemant A/S (OTCMKTS:WILYY) Sees Large Growth in Short InterestMay 8, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Repare Therapeutics (RPTX) and Demant (OtherWILLF)May 6, 2024 | finanznachrichten.deDemant A/S: Demant A/S: Interim Management Statement for Q1 2024April 28, 2024 | markets.businessinsider.comKepler Capital Keeps Their Sell Rating on Demant (WILLF)April 3, 2024 | msn.comGaston Sports Hall of Fame: Here's how baseball led Willie Gillespie to a greater purposeApril 2, 2024 | sports.yahoo.comWilly Adames has a lot to say about starting the year with a sweepMarch 31, 2024 | ftw.usatoday.comBrewers vs. Mets Player Props Today: Willy Adames - March 31February 21, 2024 | msn.comAll About The 'Willys Go-Devil' EngineFebruary 19, 2024 | msn.comDodgers hype up Gavin Lux as clock ticks on Willy Adames dreamFebruary 5, 2024 | msn.comSHOCKING! Brewers SS Willy Adames Up for GrabsFebruary 5, 2024 | msn.comBrewers SS Willy Adames Is ‘Available For Trade’: ReportJanuary 24, 2024 | realmoney.thestreet.comDemant just downgraded at HandelsbankenJanuary 11, 2024 | news.yahoo.comMike Tindall apologised for revealing Prince William’s boozy nicknameJanuary 11, 2024 | msn.comBrewers, Willy Adames avoid arbitration by agreeing to a $12.25 million contract for 2024January 4, 2024 | msn.comSurging Pelicans focusing on Willie Green's defensive principlesDecember 31, 2023 | msn.comWhatchu Talking ‘Bout Willys? You’ve Been Saying Willys Jeep Wrong for YearsDecember 27, 2023 | msn.com‘Good music never goes out of fashion’: Willie Nelson’s influence still going strong at 90December 20, 2023 | investing.comDemant A/S ADR (WILYY)November 13, 2023 | msn.comMVBrewers #10: Willy AdamesNovember 7, 2023 | reuters.comDemant Q3 revenue meets forecastNovember 7, 2023 | marketwatch.comDemant Shares Tumble on Weakness in Gaming, Corporate BusinessOctober 31, 2023 | msn.comWhy Willys M38A1 Was Retired From The MilitaryOctober 23, 2023 | msn.comRecent win, looming homecoming football game testimonial to FAMU's Willie Simmons' path | G. ThomasOctober 11, 2023 | msn.comWillie Nelson Pic ‘Willie And Me' Sets Spring Release With Quiver Distribution; Road Trip Comedy Marks Late Peter Bogdanovich's Final Screen PerformanceOctober 3, 2023 | msn.comA man was accidentally mummified 128 years ago. Now he’ll get a burial.See More Headlines Receive WILYY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Demant A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolOTCMKTS:WILYY Previous SymbolNASDAQ:WILYY CUSIPN/A CIKN/A Webwww.demant.com Phone(453) 917-7300Fax45-3927-8900Employees21,623Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio1.09 Current Ratio1.37 Quick Ratio0.95 Sales & Book Value Annual Sales$3.26 billion Price / Sales3.14 Cash Flow$1.26 per share Price / Cash Flow18.14 Book Value$3.03 per share Price / Book7.54Miscellaneous Outstanding Shares447,880,000Free FloatN/AMarket Cap$10.23 billion OptionableNot Optionable Beta0.48 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. René Schneider M.Sc (Age 51)CFO & Member of Executive Board Comp: $1.02MMr. Søren Nielsen (Age 54)CEO, President & Member of Executive Board Comp: $1.88MMr. Niels Wagner (Age 53)President of Hearing Care & Member of Executive Board Comp: $693.73kMr. Peter PudselykkeHead of Investor RelationsMs. Trine Kromann-MikkelsenVice President of Corporate Communication and SustainabilityMr. Finn Mohring (Age 59)Senior Vice President of R&D More ExecutivesKey CompetitorsSmith & NephewNYSE:SNNEnovisNYSE:ENOVAlign TechnologyNASDAQ:ALGNSTERISNYSE:STEZimmer BiometNYSE:ZBHView All Competitors WILYY Stock Analysis - Frequently Asked Questions Should I buy or sell Demant A/S stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Demant A/S in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" WILYY shares. View WILYY analyst ratings or view top-rated stocks. How have WILYY shares performed in 2024? Demant A/S's stock was trading at $21.63 at the beginning of the year. Since then, WILYY shares have increased by 5.6% and is now trading at $22.85. View the best growth stocks for 2024 here. Are investors shorting Demant A/S? Demant A/S saw a increase in short interest in April. As of April 30th, there was short interest totaling 600 shares, an increase of 100.0% from the April 15th total of 300 shares. Based on an average daily volume of 800 shares, the days-to-cover ratio is currently 0.8 days. View Demant A/S's Short Interest. How do I buy shares of Demant A/S? Shares of WILYY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:WILYY) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyDoes this make you sick?Allegiance Goldis this a buy and hold stock?Tips4TradersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Demant A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
